Jamjoom Pharmaceuticals Factory Co (SAU:4015) General and Admin. Expense: ﷼34 Mil (TTM As of Mar. 2026)


SAU:4015 Jamjoom Pharmaceuticals Factory Co SAU:4015
75 GF Score
Price ﷼147.30
GF Value ﷼182.20
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jamjoom Pharmaceuticals Factory Co General and Admin. Expense?

Jamjoom Pharmaceuticals Factory Co SAU:4015 -1.87% 75 General and Admin. Expense is ﷼34 Mil as of Mar. 2026. GuruFocus rates SAU:4015 with a GF Score™ of 75/100 and a GF Value™ of ﷼182.20 (Modestly Undervalued). The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Jamjoom Pharmaceuticals Factory Co's General and Admin. Expense for the three months ended in Mar. 2026 was ﷼24 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼34 Mil.

Jamjoom Pharmaceuticals Factory Co General and Admin. Expense Related Terms

Jamjoom Pharmaceuticals Factory Co General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Jamjoom Pharmaceuticals Factory Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jamjoom Pharmaceuticals Factory Co General and Admin. Expense Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial 11.82 19.67 28.67 28.08 32.30

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.15 20.66 16.69 -27.20 23.53
SAU:4015
75GF Score
Jamjoom Pharmaceuticals Factory Co SAU:4015
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jamjoom Pharmaceuticals Factory Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ﷼34 Mil mean?
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a General and Admin. Expense of ﷼34 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors.
Is Jamjoom Pharmaceuticals Factory Co's General and Admin. Expense too high?
Jamjoom Pharmaceuticals Factory Co's current General and Admin. Expense is ﷼34 Mil. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's General and Admin. Expense compare to ZTS and UTHR?
Jamjoom Pharmaceuticals Factory Co's General and Admin. Expense of ﷼34 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. Jamjoom Pharmaceuticals Factory Co's current General and Admin. Expense is ﷼34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼182.20, compared to a current price of ﷼147.30 — trading 19.2% below its estimated fair value. The current General and Admin. Expense is ﷼34 Mil. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current General and Admin. Expense is ﷼34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?

Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued. The current stock price of ﷼147.30 is trading 19.2% below its estimated GF Value™ of ﷼182.20. GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.

Key valuation signals for SAU:4015:

  • General and Admin. Expense: ﷼34 Mil
  • GF Value™: ﷼182.20 vs. price of ﷼147.30 (19.2% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jamjoom Pharmaceuticals Factory Co Business Description

Address Corniche Road, P.O. Box No. 6267, 1234 Al Hamra District, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
75GF Score

Get the complete analysis for SAU:4015

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼147.30
Price
﷼182.20
GF Value